Sotera Health Company (SHC) Q4 2025 Earnings Call Transcript
While the top- and bottom-line numbers for Sotera Health (SHC) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Sotera Health Company (SHC) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.21 per share a year ago.
| Professional Services Industry | Industrials Sector | Michael Petras Jr. CEO | NASDAQ (NGS) Exchange | 83601L102 CUSIP |
| US Country | 3,000 Employees | - Last Dividend | - Last Split | 20 Nov 2020 IPO Date |
Sotera Health Company specializes in offering critical sterilization, lab testing, and advisory services on both a national and international scale. The company operates its services through three primary segments: Sterigenics, Nordion, and Nelson Labs. Originating as Sotera Health Topco, Inc., the organization rebranded to Sotera Health Company in October 2020, marking its commitment to its expanding capabilities and services. Founded in 2015 and headquartered in Broadview Heights, Ohio, Sotera Health Company plays a pivotal role in various industries including medical devices, pharmaceuticals, food safety, agricultural products, cancer treatment, and high-performance materials, as well as serving advanced and specialty application industries.
Sotera Health Company provides comprehensive sterilization solutions vital for ensuring the safety and compliance of products in the medical, pharmaceutical, and food industries. These services encompass gamma and electron beam irradiation, alongside ethylene oxide processing. The company's expertise extends to designing, installing, and maintaining gamma irradiation systems, catering to the diverse needs of its clients.
With a strong focus on ensuring product safety and compliance, the company offers microbiological and analytical chemistry testing services. These are critical in verifying the integrity and efficacy of products, especially in highly regulated industries like pharmaceuticals and food safety.
Recognizing the complexities of navigating regulatory landscapes, Sotera Health Company provides clients with technical assistance, regulatory consulting, and advisory services. These services are aimed at helping companies adhere to industry standards and regulations, ensuring their products meet the necessary safety and quality requirements.